scholarly journals Risk factors for human immunodeficiency virus (HIV) infections in homosexual men.

1987 ◽  
Vol 77 (4) ◽  
pp. 479-483 ◽  
Author(s):  
W W Darrow ◽  
D F Echenberg ◽  
H W Jaffe ◽  
P M O'Malley ◽  
R H Byers ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Hiv Infections ◽  
Homosexual Men ◽  
Immunodeficiency Virus

RISK FACTORS FOR PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AMONG SEROCONVERTED AND SEROPOSITIVE HOMOSEXUAL MEN

1990 ◽  
Vol 132 (2) ◽  
pp. 203-210 ◽  
Author(s):  
GODFRIED J. P. VAN GRIENSVEN ◽  
ERNEST M. M.DE VROOME ◽  
FRANK DE WOLF ◽  
JAAP GOUDSMIT ◽  
MARIJKE ROOS ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Hiv Infection ◽  
Homosexual Men ◽  
Immunodeficiency Virus

Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men

1989 ◽  
Vol 150 (11) ◽  
pp. 634-639 ◽  
Author(s):  
Joyce L. Burcham ◽  
Geoffrey Berry ◽  
Brett Tindall ◽  
David A. Cooper ◽  
Michael Marmor ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Homosexual Men ◽  
Immunodeficiency Virus

Prevalence of and Risk Factors for Low Free Testosterone Levels in Japanese Men with Well-controlled Human Immunodeficiency Virus Infection

2020 ◽  
Vol 18 (5) ◽  
pp. 381-386
Author(s):  
Yusuke Yoshino ◽  
Ichiro Koga ◽  
Yoshitaka Wakabayashi ◽  
Takatoshi Kitazawa ◽  
Yasuo Ota
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Standard Deviation ◽  
Hiv Infection ◽  
Free Testosterone ◽  
Serum Levels ◽  
University Hospital ◽  
Rapid Decline ◽  
Total Testosterone ◽  
Immunodeficiency Virus

Background: The change in the prevalence of hypogonadism with age in men with human immunodeficiency virus (HIV) infection is subject to debate. Objective: To address this issue, we diagnosed hypogonadism based on serum levels of free testosterone (fTST) rather than total testosterone which is thought to be an inaccurate indicator. We also determined the relationship between age and fTST levels and identified risk factors for hypogonadism in men with HIV infection. Method: We retrospectively reviewed fTST levels and associated clinical factors in 71 wellcontrolled HIV-infected men who were treated at Teikyo University Hospital between April 2015 and March 2016 and who had data available on serum fTST levels, measured >6 months after starting antiretroviral therapy. fTST was measured using radioimmunoassay on blood samples collected in the morning. Risk factors for hypogonadism were identified using Welch’s t-test and multiple regression analysis. Results: The men had a mean (± standard deviation) age of 47.4 ± 13.6 years, and mean (± standard deviation) serum fTST level of 13.0 ± 6.1 pg/mL. Fifteen (21.1%) men had hypogonadism based on a fTST <8.5 pg/mL. Serum fTST levels significantly decreased with age (−0.216 pg/mL/year). Older age and low hemoglobin levels were identified as risk factors for hypogonadism. Conclusion: The men in the study experienced a more rapid decline in fTST levels with age than men in the general population (−0.161 pg/mL/year). Serum fTST levels in men with HIV infection should be monitored, especially in older men and those with low hemoglobin levels.

Changes in the Hypothalamic-Pituitary-Gonadal Axis in Human Immunodeficiency Virus-Infected Homosexual Men*

1989 ◽  
Vol 68 (2) ◽  
pp. 317-321 ◽  
Author(s):  
THOMAS S. CROXSON ◽  
WILLIAM E. CHAPMAN ◽  
LORRAINE K. MILLER ◽  
CHARLES D. LEVIT ◽  
RUBY SENIE ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Homosexual Men ◽  
Immunodeficiency Virus

scholarly journals Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017

2021 ◽  
Vol 18 (9) ◽  
pp. 4623
Author(s):  
Sherali Massavirov ◽  
Kristina Akopyan ◽  
Fazlkhan Abdugapparov ◽  
Ana Ciobanu ◽  
Arax Hovhanessyan ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Treatment Outcomes ◽  
Sputum Smear ◽  
People Living With Hiv ◽  
Tb Treatment ◽  
Cell Counts ◽  
Cd4 Cell Counts ◽  
Immunodeficiency Virus ◽  
Positive Sputum Smear

Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection poses a growing clinical challenge. People living with HIV have a higher chance of developing TB, and once the disease has progressed, are at greater risk of having unfavorable TB treatment outcomes. Data on TB treatment outcomes among the HIV-associated TB population in Uzbekistan are limited. Thus, we conducted a cohort study among 808 adult patients with HIV-associated TB registered at the Tashkent TB referral hospital from 2013–2017 to document baseline characteristics and evaluate risk factors for unfavorable TB treatment outcomes. The data were collected from medical records and ambulatory cards. About 79.8% of the study population had favorable treatment outcomes. Antiretroviral therapy (ART) coverage at the admission was 26.9%. Information on CD4-cell counts and viral loads were largely missing. Having extrapulmonary TB (aOR 2.21, 95% CI: 1.38–3.53, p = 0.001), positive sputum smear laboratory results on admission (aOR 1.62, 95% CI: 1.07–2.40), diabetes (aOR 5.16, 95% CI: 1.77–14.98), and hepatitis C (aOR 1.68, 95% CI: 1.14–2.46) were independent risk factors for developing unfavorable TB treatment outcomes. The study findings provide evidence for targeted clinical management in co-infected patients with risk factors. Strengthening the integration of TB/HIV services may improve availability of key data to improve co-infection management.

Sign in / Sign up

Export Citation Format

Share Document